Patents by Inventor Hendrik J. Vreman

Hendrik J. Vreman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090260633
    Abstract: Eye shades to reduce phototherapy light exposure to the eyes of a jaundiced person during a phototherapy session are provided. The shades includes a flexible and soft frame that can be placed against the face of a jaundiced person. At least one light-absorbing filter capable of filtering phototherapy light to both eyes of the person is affixed to the frame. The light-absorbing filter is a light intensity reduction filter of the blue-to-yellow light or the blue light from the phototherapy light. Advantages of the phototherapy shades presented herein exist due to the ability of patients to see their surroundings during phototherapy and caregivers to observe newborn's state of alertness.
    Type: Application
    Filed: April 6, 2009
    Publication date: October 22, 2009
    Inventor: Hendrik J. Vreman
  • Publication number: 20090069873
    Abstract: Transparent films for efficient phototherapy treatment of a patient and reducing phototherapy light exposure to non-patients are provided. Patients undergoing hyperbilirubinemia generally require phototherapy treatment, which can cause undesirable symptoms to non-patients, including caregivers, in the vicinity of the treatment area. Flexible transparent films are provided to at least partially reflect and/or absorb the phototherapy light, thereby providing comfort to the non-patients. Due to the at least partial transparency of the films, a non-patient can visually observe the patient to provide care to the patient. In addition, the transparent films can reflect the light down to the patient for increasing the phototherapy treatment efficacy.
    Type: Application
    Filed: August 27, 2008
    Publication date: March 12, 2009
    Inventor: Hendrik J. Vreman
  • Patent number: 6596016
    Abstract: A phototherapy garment contains a flexible backing material, a transparent liner, and a flexible printed circuit sheet containing surface-mounted light-emitting diodes (LEDs) positioned between the backing material and the liner. An infant is placed inside the garment so that the LEDs illuminate a large portion of the infant's skin for phototherapy. The LEDs preferably emit high-intensity blue light, suitable for treatment of neonatal hyperbilirubinemia or Crigler-Najjar syndrome. The LEDs are arranged in a densely packed array facing the liner and emit uniform, high intensity light. A power supply, which may be portable, supplies adjustable power to the LEDs, preferably pulsed with a duty cycle of approximately 10%, and preferably to overdrive the LEDs to maximize light output. A two-way communications device incorporated into the garment allows a physician or computer to control the garment remotely and gather relevant information periodically or continuously.
    Type: Grant
    Filed: April 19, 2000
    Date of Patent: July 22, 2003
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Hendrik J. Vreman, Daniel S. Seidman, David K. Stevenson
  • Patent number: 6350275
    Abstract: A device is provided for treating a circadian rhythm disorder in a subject. The device includes a plurality of light emitting diodes (LED's), preferably blue to green; a mounting to which the LED's are connected: a material for positioning the LED's within 3 cm of the subject, with an orientation toward the subject; a portable power supply electrically connected to the LED's; and a control connected to the LED's for altering the operation of the LED's. The device is sufficiently light and compact to be comfortably worn by the subject. One or more such devices are used to deliver light to a subject's retinas, to the subject's vascular tissue, or simultaneously to both the retinas and the vascular tissue. For illumination of the retina, small chip-type LED's are integrated into the frames of eyeglasses and positioned to direct light into the eyes of the subject.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: February 26, 2002
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Hendrik J. Vreman, David K. Stevenson
  • Patent number: 5383469
    Abstract: Apparatus for use in a hospital nursery, clinic, or physician's office for the sampling and analysis of neonatal end-tidal breath for carbon monoxide as an indication of hemolysis and subsequent infant jaundice includes a syringe and plunger for collecting end-tidal breath, a pump for supporting the syringe and including drive means for incrementally withdrawing the plunger and collecting end tidal breath, and a controller for the pump including a thermistor positionable to respond to the temperature of exhaled breath and generating an electrical signal in response to thermistor temperature. A rate detector receives the signal and determines exhalation rate. The signal is delayed in response to exhalation rate and then utilized to energize the pump in incrementally withdrawing the plunger in collecting end tidal breath. The pump can also be used in analysis equipment which extracts the end tidal breath sample with a sensor receiving the sample and determining carbon monoxide content.
    Type: Grant
    Filed: October 12, 1993
    Date of Patent: January 24, 1995
    Assignee: Board of Trustees of the Leland Stanford Junior University
    Inventors: Hendrik J. Vreman, David K. Stevenson
  • Patent number: 5081115
    Abstract: A formulation for administration of a metalloporphyrin compound useful in the treatment or prevention of jaundice is described. The formulation comprises the metalloporphyrin in admixture with an excipient which is a water-soluble organic amine, said composition having been neutralized to neutral pH. The formulation may advantageously contain a stabilizer, such as human serum albumin.
    Type: Grant
    Filed: March 24, 1989
    Date of Patent: January 14, 1992
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Hendrik J. Vreman, David K. Stevenson
  • Patent number: 4831024
    Abstract: Disclosed herein is an effective and safe method for preventing the onset of neonatal jaundice through the reduction of bilirubin production. This method can be applied to populations of infants based on mass screening procedures predictive of development of the disease. The most effective of these screening methods measures carbon monoxide production by the infants using a simple breath test.
    Type: Grant
    Filed: October 15, 1987
    Date of Patent: May 16, 1989
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Hendrik J. Vreman, David K. Stevenson